Tinavi Medical Technologies Co.Ltd(688277) independent director
Prior approval opinions on relevant matters of the 11th meeting of the 5th board of directors of the company
In accordance with the guiding opinions on the establishment of independent director system in listed companies, the articles of association of Tinavi Medical Technologies Co.Ltd(688277) (hereinafter referred to as the “articles of association”) and the working system of Tinavi Medical Technologies Co.Ltd(688277) independent directors, we, as Tinavi Medical Technologies Co.Ltd(688277) (hereinafter referred to as the “company”) ）The independent directors of the company fully reviewed the relevant matters to be submitted to the 11th meeting of the 5th board of directors, listened to the introduction and carefully reviewed the relevant documents. Based on our independent judgment, we hereby give the following prior approval opinions on relevant matters:
1. Proposal on adjusting the company’s plan to issue A-Shares to specific objects in 2021
The company’s issuance of shares to specific objects after this adjustment complies with the company law, the securities law, the measures for the administration of securities issuance registration of companies listed on the science and Innovation Board (for Trial Implementation) and other laws and regulations, normative documents and the articles of association The provisions are in line with the long-term development of the company, and there is no situation that damages the interests of the company and its shareholders, especially small and medium-sized shareholders. We agree to the proposal and agree to submit it to the board of directors of the company for deliberation.
2. On
< Tinavi Medical Technologies Co.Ltd(688277) 2021 年度向特定对象发行 A股股票预案（修订稿）>
Proposal for
In combination with the specific conditions of the revision of the issuance plan, The Tinavi Medical Technologies Co.Ltd(688277) 2021 plan for issuing A-Shares to specific objects (Revised Version) prepared by the company this time complies with the company law, the securities law, the measures for the administration of securities issuance registration of companies listed on the science and Innovation Board (for Trial Implementation) and other laws, regulations, normative documents and the articles of association The provisions are in line with the long-term development of the company, and there is no situation that damages the interests of the company and its shareholders, especially small and medium-sized shareholders. We agree to the proposal and agree to submit it to the board of directors of the company for deliberation.
3. About
<公司 2021 年度向特定对象发行 A 股股票方案的论证分析报告（修订稿）>
Proposal for
The demonstration and analysis report on the scheme of issuing A-Shares to specific objects in Tinavi Medical Technologies Co.Ltd(688277) 2021 (Revised Version) prepared by the company this time Taking into account the company’s industry and development stage, capital planning, capital demand and other conditions, this paper fully demonstrates the necessity of the selection of securities and their varieties, the appropriateness of the issuance object, the rationality of the issuance pricing, the feasibility of the issuance method, and the fairness and rationality of the issuance scheme, and there is no behavior damaging the interests of the company and all shareholders, especially small and medium-sized shareholders, Comply with relevant laws, regulations and normative documents. We agree to the proposal and agree to submit it to the board of directors of the company for deliberation.
Independent director: Dai Changjiu, Wang Guangzhi, Li Yan date: December 22, 2021
